Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.24, $0.09 better than the analyst estimate of $0.15. Revenue for the quarter came in at $32.5 million versus the consensus estimate of $31.48 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.